SynthesisFrontiers in pharmacology2019

Efficacy and Safety in the Continued Treatment With a Biosimilar Drug in Patients Receiving Infliximab: A Systematic Review in the Context of Decision-Making From a Latin-American Country.

Edward Mezones-Holguin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.